Systematic Review of Health Economic Analyses of Measles and Rubella Immunization Interventions. (Q38302410)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25545778%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

review article

1 reference

title

Systematic Review of Health Economic Analyses of Measles and Rubella Immunization Interventions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25545778%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25545778%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Cassie L Odahowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25545778%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

language of work or name

1 reference

24 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25545778%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25545778%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25545778%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25545778%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

1297-1314

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25545778%20AND%20SRC:MED&resulttype=core&format=json

Characterization of the Risks of Adverse Outcomes Following Rubella Infection in Pregnancy

26 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Systematic Review of the Manifestations of Congenital Rubella Syndrome in Infants and Characterization of Disability-Adjusted Life Years (DALYs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Benefits due to immunization against measles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Pharmacoeconomics of immunisation: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Systematic review of economic evaluation analyses of available vaccines in Spain from 1990 to 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Health economics of rubella: a systematic review to assess the value of rubella vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

The Pediatric Economic Database Evaluation (PEDE) Project: establishing a database to study trends in pediatric economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Assessment of susceptibility to measles and rubella

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Serologic screening, mass immunization, and implications for immunization programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Prevaccination serologic screening for measles in health care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Critical prevalence of antibodies minimizing vaccination costs for hepatitis A, hepatitis B, varicella, measles and tetanus in adults and adolescents in Catalonia, Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Cost-effectiveness analysis of MMR immunization in health care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Cost-effectiveness analysis of rubella screening strategies using electronic medical records

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Cost-minimization analysis of the U.S. Army accession screening and immunization program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

To screen or to vaccinate? A decision analysis for rubella prevention on campus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Protection of medical and paramedical university students in Lebanon against measles, mumps, rubella and varicella: active measures are needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Should all children receive two measles vaccinations? A study of measles susceptibility in a suburban New Jersey private practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Seropositivity rates for measles, mumps, and rubella IgG and costs associated with testing and revaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Computer-generated recall letters for underimmunized children: how cost-effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Measuring the cost-effectiveness of a national health communication program in rural Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Jet injector: appraisal of its use in a local setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

The price of prevention. cost of recommended activities to improve immunizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Measles vaccination with reduced dosage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Single versus multi-dose vaccine vials: an economic computational model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Replacing the measles ten-dose vaccine presentation with the single-dose presentation in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Economic analysis of investment priorities for measles control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Setting priorities for the Children's Vaccine Initiative: a cost-effectiveness approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

An economic evaluation of thermostable vaccines in Cambodia, Ghana and Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Routine high-dose vitamin A therapy for children hospitalized with measles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Multicenter evaluation of a novel quantification method for rubella and toxoplasmosis antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

The cost of containing one case of measles: the economic impact on the public health infrastructure--Iowa, 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Costs of congenital rubella syndrome (CRS) in Oman: evidence based on long-term follow-up of 43 children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Further efforts needed to achieve measles elimination in Germany: results of an outbreak investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Health Care-Associated Measles Outbreak in the United States After an Importation: Challenges and Economic Impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

A locally initiated and executed measles outbreak response immunization campaign in the nylon health district, Douala Cameroon 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

The economic burden of sixteen measles outbreaks on United States public health departments in 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Evolution of rubella vaccine policy for the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Insights from epidemiological game theory into gender-specific vaccination against rubella

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

A game dynamic model for vaccine skeptics and vaccine believers: measles as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Free-riding behavior in vaccination decisions: an experimental study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Vaccination and the theory of games

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Synthesizing epidemiological and economic optima for control of immunizing infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Optimal vaccination choice, vaccination games, and rational exemption: An appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Strategic planning for measles control: using data to inform optimal vaccination strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Benefit-cost analysis of rubella vaccination policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

A Cost-Benefit Analysis of a Mandatory Premarital Rubella-Antibody Screening Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Cost-effectiveness of the expanded programme on immunization in the Ivory Coast: a preliminary assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Formula for calculating vaccine profitability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Costs and benefits of a second measles inoculation of children in Israel, the West Bank, and Gaza

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Economic benefits of a routine second dose of combined measles, mumps and rubella vaccine in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

A model to estimate the potential economic benefits of measles eradication for the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Cost-effectiveness of measles outbreak intervention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Fuzzy logic and measles vaccination: designing a control strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

A comparison of alternate immunization regimes for measles in vaccinated populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Economic evaluation of options for measles vaccination strategy in a hypothetical Western European country

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Future savings from measles eradication in industrialized countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Impact of Alternative Approaches to Accelerated Measles Control: Experience in the African Region, 1996–2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Cost-effectiveness of three different vaccination strategies against measles in Zambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Strengthening health services to control epidemics: empirical evidence from Guinea on its cost-effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Economic Evaluation of the 7-Vaccine Routine Childhood Immunization Schedule in the United States, 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Cost effectiveness analysis of strategies for child health in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Economic evaluation of measles catch-up and follow-up campaigns in Afghanistan in 2002 and 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Health burden and economic impact of measles-related hospitalizations in Italy in 2002-2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

A cost-utility analysis of antenatal screening to prevent congenital rubella syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Assessing the Cost-Effectiveness of Measles Elimination in Uganda: Local Impact of a Global Eradication Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Global Eradication of Measles: An Epidemiologic and Economic Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

The economic disease burden of measles in Japan and a benefit cost analysis of vaccination, a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Measles outbreak in an asylum-seekers' shelter in Germany: comparison of the implemented with a hypothetical containment strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Economic evaluation of a Child Health Days strategy to deliver multiple maternal and child health interventions in Somalia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Supplementary immunization activities (SIAs) in South Africa: comprehensive economic evaluation of an integrated child health delivery platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

Economic evaluation of the routine childhood immunization program in the United States, 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12331

21 January 2018

Identifiers

DOI

10.1111/RISA.12331

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25545778%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25545778%20AND%20SRC:MED&resulttype=core&format=json